Bubs Australia (ASX:BUB) — Material Events

ASX:BUB · 10 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 7 articles Notable 3 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
7
Bubs Australia Posts 29% Revenue Surge and Returns to Profitability in FY25High
Bubs posts 29% revenue growth, positive EBITDA and cash flow in FY25; FDA submission underway
28 July 2025 ·Appendix 4C Quarterly Cash Flow and Activities Report ·85
Bubs Australia Boosts Revenue 30% with Strong US Growth and Positive EBITDAMedium
Bubs Australia posts 30% revenue growth in Q1 FY26 with positive EBITDA and strong USA performance
31 Oct 2025 ·Quarterly Activities Report and Appendix 4C ·85
Bubs Australia’s FY25 Profit Surges 124% Amid FDA Approval HopesHigh
Bubs Australia posts FY25 profit of $5.17m on 29% revenue growth, eyes FDA approval
29 Aug 2025 ·Appendix 4E Preliminary Final Report ·Unexpected ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.